Jacob Thaysen

Illumina shares suffered an 18.6% selloff despite stronger earnings and an upgraded 2026 outlook. A US$42 million net tariff-refund benefit, uneven sequencing demand and demanding valuation expectations reveal why investors are questioning the sustainability of its recovery.